GNRH1 and cancer: PDCs with the anticancer drug gemcitabine and D-Lys6-GnRH (gonadotropin-releasing hormone; GnRH) as a cancer-targeting material induced the separation of drugs from GOXG at pHen and pHlys through breakage of the acid-labile oxime bond.